Follow Up Care for Children Prescribed ADHD Medication (ADD) by Subpopulation-Continuation Phase

HEDIS® Measurement Description: The Percentage of members who are newly prescribed attention-deficit/hyperactivity disorder (ADHD) medication, who had one follow-up visit with a practitioner with prescribing authority during the 30-day Continuation Phase.

Measure Identifier: HEDIS_ADD.02_SUB

Please see Report Details below for more information on selected subgroups, organizations, and aggregation.



*HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).